HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition

Autor: Sharon Walmsley, Satya Dandekar, M. Tozammel Hoque, Sumathi Sankaran-Walters, Reina Bendayan, Olena Kis
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Microarray
Abcg2
HIV Infections
ATP-binding cassette transporter
Pharmacology
Subfamily G
2.1 Biological and endogenous factors
ATP Binding Cassette Transporter
Subfamily G
Member 2

Cytochrome P-450 CYP3A
Medicine
Pharmacology (medical)
Aetiology
chemistry.chemical_classification
biology
Multidrug resistance-associated protein 2
Pharmacology and Pharmaceutical Sciences
Middle Aged
Immunohistochemistry
Multidrug Resistance-Associated Protein 2
Infectious Diseases
Real-time polymerase chain reaction
Subfamily B
5.1 Pharmaceuticals
Medical Microbiology
6.1 Pharmaceuticals
HIV/AIDS
Female
Development of treatments and therapeutic interventions
Multidrug Resistance-Associated Proteins
Infection
Member 2
Adult
Member 1
ATP Binding Cassette Transporter
Subfamily B

Anti-HIV Agents
ATP Binding Cassette Transporter
Real-Time Polymerase Chain Reaction
Microbiology
03 medical and health sciences
Clinical Research
Humans
ATP Binding Cassette Transporter
Subfamily B
Member 1

CYP3A4
business.industry
Prevention
Evaluation of treatments and therapeutic interventions
030104 developmental biology
Enzyme
chemistry
Immunology
HIV-1
biology.protein
Transcriptome
business
Zdroj: Antimicrobial agents and chemotherapy, vol 60, iss 5
ISSN: 1098-6596
0066-4804
DOI: 10.1128/aac.02278-15
Popis: This study investigated the effects of HIV-1 infection and antiretroviral therapy (ART) on the expression of intestinal drug efflux transporters, i.e., P-glycoprotein (Pgp), multidrug resistance-associated proteins (MRPs), and breast cancer resistance protein (BCRP), and metabolic enzymes, such as cytochrome P450s (CYPs), in the human upper intestinal tract. Intestinal biopsy specimens were obtained from HIV-negative healthy volunteers, ART-naive HIV-positive (HIV + ) subjects, and HIV + subjects receiving ART (10 in each group). Intestinal tissue expression of drug transporters and metabolic enzymes was examined by microarray, real-time quantitative reverse transcription-PCR (qPCR), and immunohistochemistry analyses. Microarray analysis demonstrated significantly lower expression of CYP3A4 and ABCC2 /MRP2 in the HIV + ART-naive group than in uninfected subjects. qPCR analysis confirmed significantly lower expression of ABCC2 /MRP2 in ART-naive subjects than in the control group, while CYP3A4 and ABCG2 /BCRP showed a trend toward decreased expression. Protein expression of MRP2 and BCRP was also significantly lower in the HIV + naive group than in the control group and was partially restored to baseline levels in HIV + subjects receiving ART. In contrast, gene and protein expression of ABCB1 /Pgp was significantly increased in HIV + subjects on ART relative to HIV + ART-naive subjects. These data demonstrate that the expression of drug-metabolizing enzymes and efflux transporters is significantly altered in therapy-naive HIV + subjects and in those receiving ART. Since CYP3A4, Pgp, MRPs, and BCRP metabolize or transport many antiretroviral drugs, their altered expression with HIV infection may negatively impact drug pharmacokinetics in HIV + subjects. This has clinical implications when using data from healthy volunteers to guide ART.
Databáze: OpenAIRE